Dr Ogdie is Associate Professor of Medicine and Epidemiology, and Deputy Director of the Center for Clinical Epidemiology and Biostatistics in the Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA and is Director of the Penn Psoriatic Arthritis and Spondyloarthritis Program.
Dr Ogdie’s research program focuses on pharmacoepidemiology and observational studies of psoriatic arthritis (PsA). The mission of her research is to improve outcomes in PsA by accelerating diagnosis, increasing the focus on meaningful, patient-centered outcomes, and in developing and advancing methods for precision medicine. Her areas of expertise include epidemiology and pharmacoepidemiology, biostatistical methods for observational studies (e.g. time to event modeling, prediction modeling), outcome measures (e.g. qualitative and quantitative/psychometric assessment), clinical trial design and more general qualitative methods (e.g. survey, focus group and interview studies).
Dr Ogdie’s recent work has focused on pragmatic trial design in PsA, which is the basis for an R01 funded by NIAMS (R01 AR072363), and trial simulation studies to inform pragmatic trial design, with statistical collaborator Alisa Stephens. Dr Ogdie is currently co-leading a trial to examine the impact of dietary interventions on PsA disease activity and conducted a pilot trial of physical activity in inflammatory arthritis. Both trials employ concepts from behavioral economics to enhance the effectiveness of the interventions. Recently, her research group has focused their efforts on early identification of PsA through a better understanding of the predictors of disease and how this can be implemented in electronic medical records. They are also working on design of a trial to test prevention of PsA through the treatment of psoriasis.